Russia enters final stage of clinical trial of drug to treat Covid patients

The Economic Times reports:
Russian Direct Investment Fund (RDIF), Russia's sovereign wealth fund, and ChemRar Group on Friday announced the start of the final stage of the multicenter randomized open comparative clinical trial of the drug Favipiravir on patients hospitalized with COVID-19. On 21 May, the Ministry of Health of the Russian Federation approved the launch of the final stage, which will involve 330 patients compared to 60 during the initial stage, as well as additional research and medical centers.
Continue reading...   Comments   FAQ
This story is trending. Share it.